NEW YORK (GenomeWeb News) – The University of Southern California’s Keck School of Medicine has landed a $24 million gift from media mogul Sumner Redstone to fund molecular research into prostate cancer, USC said this week.
The research will involve genomics and proteomics and will be led by David Agus, who is director of the USC Center for Applied Molecular Medicine and the USC Westside Prostate Cancer Center and a co-founder of Navigenics, the Keck School of Medicine said in a statement.
“We are working on new treatments for prostate cancer, and this tremendous philanthropic gift from Sumner allows our team to think outside of the box,” Argus said in a statement.
Argus said that the funding from Redstone “gives us free rein to think about the world in a different way, and he pushes us to be more entrepreneurial by focusing on incremental gains and taking risks in areas where there are more breakthrough opportunities.”
Agus’ research efforts focus on applying genomics and proteomics in cancer research aimed studying molecular switches involved in cancer progression and response to treatment.
“I was fortunate to meet Dr. Agus shortly after I was diagnosed with prostate cancer and since that time, I have benefitted from his expertise,” Redstone said.
“He quite literally saved my life, as he has done for many others,” he added.